By Sunovion Pharmaceuticals Inc. This app is intended only for US healthcare professionals involved in the treatment of adult patients with bipolar disorder and is for educational purposes only. This program was developed in collaboration with expert faculty and is provided by Sunovion Pharmaceuticals Inc. The information contained in the app is intended for general informational purposes only and is not a substitute for your professional medical advice and judgment. Tap into expert approaches for diagnosing and treating bipolar depression with this unique app. A multidisciplinary faculty consisting of 2 psychiatrists, 2 primary care physicians, and a psychiatric nurse practitioner will walk you through 6 hypothetical patient case studies depicting approaches to common disease-management challenges. The app also puts a variety of helpful tools and resources at your fingertips, including 5 validated screening tools, a review of relevant DSM-5 updates, and an overview of a potential treatment option. Download this educational clinical companion today. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd. ©2015 Sunovion Pharmaceuticals Inc. All rights reserved. LAT154-15 06/15 less
|
